Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
Anthrax
About this trial
This is an observational trial for Anthrax focused on measuring Anthrax, Immune Globulin, Plasmapheresis, Vaccine
Eligibility Criteria
INCLUSION CRITERIA: Age range 18 to 65 years. Weight greater than 110 pounds. Fingerstick hemoglobin greater than or equal to 12.5 g/dL. No known heart, lung, kidney disease, or bleeding disorders. No history of hepatitis since age 11. No history of intravenous injection drug use. No tattoos or non-sterile skin piercing within the past 12 months. No history of engaging in high-risk activities for exposure to AIDS or hepatitis viruses, as defined in the DTM "Donor Alert." Female subjects should not be pregnant. Completion of a primary AVA vaccination series (0, 2, 4 weeks and 6 months) and be within 3 to 12 weeks of receiving a dose at 6 months, 12 months, or 18 months; or within 6 months of an annual booster.
Sites / Locations
- Warren G. Magnuson Clinical Center (CC)